TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.

Christos VaklavasBrian S RobertsKatherine E VarleyNancy U LinMinetta C LiuHope S RugoShannon PuhallaRita NandaAnna Maria StornioloLisa A CareyMansoor N SalehYufeng LiJennifer F DelossantosWilliam E GrizzleAlbert F LoBuglioRichard M MyersAndres Forero-Torresnull null

Published in: Breast cancer research : BCR (2020)

This trial is registered with ClinicalTrials.gov (Identifier: NCT00161291), first posted on September 12, 2005, and is completed.

Keyphrases

phase ii
open label
phase iii
clinical trial
newly diagnosed
double blind
placebo controlled
phase ii study
study protocol
patients undergoing
bone mineral density
randomized controlled trial
polycystic ovary syndrome
radiation therapy
skeletal muscle
early breast cancer